Hearing loss is one of the major medical concerns in girls and women with Turner syndrome (TS) and has a negative effect on well-being and quality of everyday life. Sensorineural hearing loss is the most common type of hearing loss, affecting more than half of adults with TS. Karyotypes with a loss of the short p-arm on the X-chromosome are more prone to ear and hearing problems. The importance of detecting, investigating, and treating hearing loss with hearing aids cannot be emphasized enough. The pathophysiology of the sensorineural hearing loss in TS is not known, but theories regarding estrogen deficiency, the cell cycle delay hypothesis, IGF-1 deficiency and the possible role of the KDM6A gene are discussed. Due to the diversity of symptoms and conditions within the same karyotype, a combination of genetic factors altered by epigenetic and/or hormonal effects is probable. Further research is needed regarding the pathophysiology of ear and hearing problems in TS to develop new treatment methods. The pathophysiology behind the sensorineural hearing loss in TS is unclear and some theories have been presented over the years.
communication in daily life starts to become more challenging.
According to Lin et al., 2011 , the prevalence of hearing loss in a civilian, noninstitutionalized U.S. population was 0. 35, 0.79, 4.5, 6.1, and 16.1%, respectively, for women in their 20s, 30s, 40s, 50s, and 60s (Lin et al., 2011) .
For girls and women with Turner syndrome (TS), hearing loss is one of the major medical concerns, negatively affecting their wellbeing and quality of life (Carel et al., 2005; Carel, Bastie-Sigeac, Ecosse, Coste, & Co, 2004; Hultcrantz, 2003) .
In a cohort of women with TS in Sweden, between 25 and 38 years of age, only 48% had a normal hearing level in the better ear (here defined as a PTA4 < 20 dB HL), whereas 45% had a mild loss (PTA4 20-39 dB HL) and 7% had a moderate or severe loss (PTA4 > 39 dB HL) (Bonnard, Bark, & Hultcrantz, 2017) . King et al. (2007) demonstrated comparable figures in a group of 202 women with TS aged 7-61 (King et al., 2007) . Other studies have similarly shown high prevalence figures in several studied groups of young adults with TS, but as the criteria for defining grade of hearing loss vary comparisons are difficult (Oliveira, Ribeiro, Lago, & Alves, 2013; Ostberg, Beckman, Cadge, & Conway, 2004) . On an average, the hearing thresholds in women with TS are comparable to those of women in the general population at least 20 years older than their age group (Bonnard et al., 2017) .
The pathophysiology behind the sensorineural hearing loss in TS is unclear and some theories have been presented over the years.
Women with TS have a lack of estrogen and an early debut of highfrequency hearing loss, similar to that seen in men. This has led to the Estrogen-theory, which is based on the difference in estrogen levels throughout life between women and men. The high-frequency hearing loss is developed in about the same age-span in men as in women with TS.
The short stature homeobox containing-gene (SHOX-gene) deficiency has been identified to cause the short stature in TS. Women with a karyotype affecting the short arm of the X-chromosome are also more prone to have ear and hearing problems (Cameron-Pimblett, La Rosa, King, Davies, & Conway, 2017) . This is the base for the cell cycle delay hypothesis or the SHOX-gene theory, founded on the SHOX-gene deficiency affecting the formation of the inner ear.
Recent advances in genetics point toward an important impact generated by epigenetic effects due to the haploinsufficiency. Several genes on the X-chromosome have been showed to have regulatory effects on other genes, both on the X-chromosome and on the autosomal chromosomes (Alvarez-Nava & Lanes, 2018). There is also an ongoing search for candidate genes where some resemblance with the ear and hearing problems in Kabuki syndrome has attracted the interest to the KDM6A gene (UTX) on the X-chromosome (Peterson-Falzone, Golabi, & Lalwani, 1997) .
The aim of this article is to present the current knowledge of sensorineural hearing loss in TS, treatment options, and theories presented in the literature regarding the pathophysiology.
| SENSORINEURAL HEARING LOSS IN TS

| Clinical presentation
Most children with TS are born with normal hearing thresholds. Early in life they have frequent problems with otitis media often leading to prolonged periods of conductive hearing loss. It is common that the middle ear problems become chronic, implying needs for surgery and/or hearing rehabilitation. The otitis problems decline during and after puberty, often leaving permanent conductive hearing loss of varying degrees (Hultcrantz & Sylven, 1997; Hultcrantz, Sylven, & Borg, 1994; Stenberg, Nylen, Windh, & Hultcrantz, 1998; Verver et al., 2014) . Complications such as chronic otitis media, and cholesteatoma are overrepresented in this group (Lim et al., 2014) .
In puberty and early adulthood, but rarely before school age, a pattern of sensorineural hearing loss is seen as a dip in the midfrequencies in up to 50% of individuals with TS and has been detected as early as at the age of 5 (Hultcrantz & Sylven, 1997; Roush, Davenport, & Carlson-Smith, 2000) . This loss usually progresses over time, and can become quite marked, without disturbing daily life communication significantly as long as the high frequencies are not affected.
With increasing age an additional pattern becomes apparent-a high frequency decline, resembling age-related hearing loss (Hultcrantz et al., 1994) . This type of hearing loss poses more problems, as it affects the detection of sounds that are crucial for discriminating speech. All women do not develop both these patterns of hearing loss, but the midfrequency dip in puberty/early adulthood is a predictor of a future high rate of hearing decline with social consequences (Hederstierna, Hultcrantz, & Rosenhall, 2009) 
| Treatment
The hearing problems associated with frequent otitis media in childhood can be prevented to a certain extent with regular ENT- (Gravholt et al., 2017) . Currently, there is no medical or surgical treatment for the sensorineural hearing loss per se, as long as it is within the mild to moderate range. Hearing aids are effective at improving different aspects of quality of life in patients with mild to moderate hearing loss (Ferguson et al., 2017) . In cases of severe and especially profound hearing loss cochlear implants may be a realistic alternative. There is no strong evidence that treatment with growth hormone (GH) or estrogens in childhood and puberty has significant effects on the degree or development of hearing loss in TS, but further long-term studies are warranted in this regard (Davenport et al., 2010; King et al., 2007) .
| THE ESTROGEN THEORY
The most striking difference between hearing in men and women is the earlier development of a high frequency hearing loss in men, but in old age this difference is not quite as apparent. The gender difference may, in part, be attributed to different patterns of noise exposure, but the differences are apparent even in non-noise exposed populations (Jerger, Chmiel, Stach, & Spretnjak, 1993; Rosenhall & Pedersen, 1995) . This has led to the theory of a protective effect of estrogen on hearing, but the relationship between estrogen and auditory function is complex.
| The estrogen receptors and their role in hearing
There are two classes of ERs: nuclear estrogen receptors (ERα and ERβ), which are members of the nuclear receptor family of intracellular receptors and mediate its effects through genomic mechanisms; and membrane estrogen receptors (mERs), which are a group of cell surface receptors that bind estrogen and rapidly exerts its effect via modulation of intracellular signaling cascades (Micevych & Kelly, 2012; Soltysik & Czekaj, 2013) .
Estrogen can also exercise its effect via estrogen-related receptors (ERRs), which are orphan nuclear receptors and the identity of their endogenous ligand has yet to be explicitly determined (Divekar, Tiek, Fernandez, & Riggins, 2016) . These three paralogue receptors: ERRα (ESRRA), ERRβ (ESRRB), and ERRγ (ESRRG) all share a high structural homology with the classical ERs but do not appear to directly bind estrogens (Tremblay & Giguere, 2007) .
According to previous studies, it is known that estrogen receptors (ERα and ERβ) are present in the inner ear of humans, rodents and fish, at locations important for sound transmission (Forlano, Deitcher, & Bass, 2005; Stenberg et al., 2001; Stenberg, Wang, Sahlin, & Hultcrantz, 1999) . Their expression in the inner ear can be upregulated or downregulated depending on the circulating levels of estrogen in the body during various stages in life Simonoska, Stenberg, Masironi, Sahlin, & Hultcrantz, 2009 ). There are many studies investigating how estrogen affects hearing function, but the exact mechanism is still not known.
Numerous ER knock-out mouse models have been used to study the effect of different ERs. In the brain of ERβ −/− knock-out (BERKO) mouse, several morphological abnormalities could be revealed with increasing age (Wang, Andersson, Warner, & Gustafsson, 2001) . Regarding hearing, this mouse exhibits early onset of hearing impairment, with deafness occurring at 12 months of age (Simonoska, Stenberg, Duan, et al., 2009; Simonoska, Stenberg, Masironi, et al., 2009 ). In the young BERKO mouse, increased susceptibility to acoustic trauma was seen, which was not the case for the young ERα −/− knock-out (ERKO) mouse (Meltser et al., 2008) , indicating that ERβ is important in maintaining hearing. In ovariectomized rats, with low estrogen levels, the noise exposure may cause greater damage to auditory function. In a clinical scenario, this can be compared to the hearing situation for women with low estrogen levels, for example, menstrual cycle, pregnancy, or induced menopause. Thus, women may have a higher risk of noise-induced hearing loss than men when the production of female estrogen decreases (Hu, Wang, & Lau, 2016) . It is interesting that many of the genes, which cause deafness when silenced, are ERβ regulated genes, such as connexin 26, cadherin, procadherin 15, and myosin. They have all been found to be underexpressed in different organs in ERβ−/− mice (Lindberg et al., 2003) .
Also, Esrrg mRNA has been found in the mouse embryonic inner ear (Hermans-Borgmeyer, Susens, & Borgmeyer, 2000) , and in Esrrg knock-out mouse, the hearing was found impaired, with a mild hearing impairment at 5 weeks of age that did not progress by time (Nolan et al., 2013) . Esrrg is known to regulate a network of genes responsible for controlling the ion homeostasis in tissues with high metabolic demand, and one such gene is Kcne1(21q22.12), which is found to be involved in potassium ion transportation and to be downregulated in Esrrg KO mouse (Alaynick et al., 2010) . Mice with targeted deletion in the Kcne1 gene show a profound hearing loss (Warth & Barhanin, 2002) . Even ESRRβ is expressed in cochlear structures. It controls epithelial cell fate and endolymph production by the stria vascularis and is important for development and to sustain endolymphatic potential by regulating transcription of the potassium ion transporter proteins such as KCNE1, KCNQ1 (11p15.4-5), and ATP1B2 (17p13.1) (Chen & Nathans, 2007) .
| Estrogen in TS
In TS, human fetuses lacking an X-chromosome exhibit ERs in the inner ear and therefore the hearing loss is not due to the loss of receptor (Stenberg et al., 2001) . In a mouse model, which is naturally estrogen-deficient but has a normal pattern of ERs (Stenberg et al., 2002) , the "Turner mouse" (39,X), early hearing loss and longer auditory brainstem response (ABR) latencies have been observed (Hultcrantz, Stenberg, Fransson, & Canlon, 2000) . This implies that its hearing loss has a cochlear origin with a central component engaging the eighth cranial nerve, resembling that of the ER β −/− knock-out mouse. The Turner mouse is known to have many characteristic features of the girls and women with TS, such as similar hearing problems (Hultcrantz et al., 2000) . The ear problems are due to middle ear (acute, serous and chronic otitis media) and inner ear derangements (progressive sensorineural dip and premature aging) (Hultcrantz et al., 1994; Stenberg et al., 1998; Watkin, 1989 ).
Significant changes in ABR have been demonstrated for ovariectomized rats compared to intact-ovary rats and reversed by estrogen replacement (Coleman, Campbell, Cooper, Welsh, & Moyer, 1994) . In a study by Stenberg, Simonoska, Stygar, Sahlin, & Hultcrantz, 2003, ovariectomized rats were administered estrogen, an upregulation of ERs was seen in the stria vascularis, an area in the inner ear where water and fluid balances are regulated (Erichsen et al., 1996; Stenberg et al., 2003) . The beneficial effect of estrogen on hearing is also seen in a study where premenopausal female mice were found to have better hearing than males, an advantage that diminishes in old age (postmenopause) (Guimaraes, Zhu, Cannon, Kim, & Frisina, 2004) .
4 | SNHL AND THE X-CHROMOSOME
| Ear and hearing and the X-chromosome
Due to the haploinsufficiency of the X-chromosome or part of one, there has been an interest in finding a genetic reason for the ear and hearing problems in TS located on the X-chromosome. As the short arm is more often affected, a search for an ear and hearing gene on this location has been the goal, but so far, no single candidate gene has been found. A few theories have been put forward and will be discussed further.
The development within the field of genetics is exponential and during the last decade, several epigenetic possibilities that can affect the phenotype, other than a direct effect of a single gene, have been detected (Alvarez-Nava & Lanes, 2018). In autosomal chromosomes, one copy of the gene is usually silenced and the other one transcribed, but in the sex-chromosomes about 15% of the genes escape silencing and are transcribed from both chromosomes (Carrel & Willard, 2005) . In TS, the lack of one, or part of one X-chromosome, leads to a haploinsufficiency of genes that would normally not have been silenced. Many genes on the X-chromosome have epigenetic effects why this can lead to changes on other autosomal chromosomes and therefore widening the possibilities for affected genes to all autosomal chromosomes as well as the X-chromosome (Trolle et al., 2016) (Denes, Landin-Wilhelmsen, Wettergren, Bryman, & Hanson, 2015) , (c) the lack of the growth-promoting SHOX-gene (Xp22.33) that would negatively affect the growth of the scull base (Ross et al., 2001) , and finally (d) a lack of IGF-1, fundamental for the formation of the otic capsule during fetal development (Leon et al., 1995) . All this was hypothesized to lead to a slower growth and therefore a decreased differentiation of the branchial arches and neck region leading to outer ear malformations; a growth disturbance of the mastoid, cranial base and Eustachian tube causing an increased risk for otitis media; and finally, a downregulated development of inner ear hair cells in the organ of Corti, giving rise to a sensorineural hearing loss (Barrenas et al., 2000) .
Other studies have supported the correlation between karyotype 45,X or loss of the short arm on the X-chromosome and sensorineural hearing loss (King et al., 2007; Oliveira & Alves, 2011; Verver et al., 2011) but an assuring connection between the SHOX-gene and sensorineural hearing loss has not yet been established (Davenport et al., 2010) . IGF-1 is essential for inner ear development and decreasing levels might affect sensorineural hearing thresholds in aging mice (Murillo-Cuesta, Rodriguez-De La Rosa, Cediel, Lassaletta, & Varela-Nieto, 2011; Riquelme et al., 2010) . A reduction in free IGF-1 and increased IGFB-3 proteolysis in women with TS have been reported (Gravholt, Frystyk, Flyvbjerg, Orskov, & Christiansen, 2001 ).
Regarding the cell cycle delay due to trisomies and a decrease in monosomic cells over the years, studies supporting this hypothesis beyond the above mentioned are lacking.
| The KDM6A (UTX) gene
Immune deficiency, leading to recurrent otitis media and hearing loss of mostly conductive type but also sensorineural type, is among the features of Kabuki syndrome that resemble the ear and hearing findings in TS (Barozzi et al., 2009; Peterson-Falzone et al., 1997) . Kabuki syndrome, also characterized by a distinct face, growth deficiency, mild to moderate mental intellectual disability and cardiovascular, renal and skeletal malformations, can be caused by a mutation in the KDM6A (UTX) gene located on the short arm of the X-chromosome (Xp11.3) (Stagi, Gulino, Lapi, & Rigante, 2016) . This is normally an Xchromosome escape gene that works as an epigenetic regulator via methylation of DNA (Greenfield et al., 1998) and has been identified as downregulated in individuals with TS (Cook et al., 2015; Trolle et al., 2016) . Mouse models with mutations in this gene show impaired clearance of viral infections due to a decrease in Tfh cells (T follicular helper cells) and this impairment has also been indicated in women with TS (Cook et al., 2015) . The KDM6A gene is a strong candidate in explaining features regarding ear infections and conductive hearing loss in TS, but its part in sensorineural hearing loss other than a secondary toxic effect is more difficult to establish and further research is needed.
| FUTURE RESEARCH
The GH-IGF-1 axis can potentially affect the inner ear in fetal development and throughout life. A disturbance in IGF-1 levels, partially modulated by estrogen treatment, has been showed (Gravholt et al., 2001 ) as well as a relation between low IGF-1 and increased sensorineural hearing loss (Barrenas et al., 2000) . The GH treatment has not been shown to increase the incidence of otitis media or hearing loss in short term (Davenport et al., 2010; Hamelin, Anglin, Quigley, & Deal, 2006) , but long-term follow-up with age-compared groups are lacking.
Estrogen has been shown to be an important gene-regulator and several ERβ-regulated genes are known genes involved in deafness. 
| SUMMARY
Sensorineural hearing loss is a significant problem in TS. The exact pathophysiology is not clearly understood, but several factors, genetic, epigenetic and hormonal, are probably contributing to the different audiometric features, alone or in combination. More research is needed to enhance the understanding of the pathophysiology to develop new treatment methods. In the meantime, hearing loss needs to be investigated and treated with hearing aids when necessary to avoid a negative effect on well-being and quality of life.
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